Introduction
Cardiovascular diseases remain the leading cause of morality in the western world. The aim of this chapter is to understand the pathogenesis of acute coronary syndromes from atherosclerotic plaque formation, to plaque progression and vascular remodeling, to plaque destabilization, to ultimately plaque rupture or erosion and thrombus formation. A cascade of interacting factors leads to plaque formation, progression, fraglisation, and rupture. Features associated with plaque rupture are: large eccentric soft lipid core, thin fibrous cap, inflammation in the cap and adventitia, increased plaque neovascularity, and outward or positive vessel remodeling. Vasospasm is a separate mechanism for developing ACS without plaque rupture or erosion will not be discussed in this chapter.
Atherosclerosis
Atherosclerosis is a chronic disease that can remain asymptomatic through decades. It is enhanced by modifiable and non modifiable risk factors and consists of intra intimal accumulation of intra cellular and extracellular oxidized LDL, macrophages, T cells, smooth muscle cells, proteoglycan, collagen, calcium, and necrotic debris. Low endothelial shear stress can contribute to atherosclerotic plaque formation, vulnerabilisation, and rupture. Intimal accumulation of oxidized LDL-C, called fatty streaks constitutes the earliest histopathologic stage of atherosclerosis. Adhesion molecules expressed by endothelial cells mediate the rolling and adhesion of circulating leukocytes on the endothelial surface. Chemoattractant chemokines promote transmigration of leukocytes into the intima. Monocytes infiltrate beneath the endothelium, differentiate to macrophages, phagocytose the oxidized LDL-C and transform into foam cells. Foam cells produce cytokines, growth factors, reactive oxygen species and matrixdegrading enzymes, sustaining atherosclerosis progression. The intensity of oxidized LDL-C accumulation in the subendothelial space is a major stimulus for the ongoing inflammatory process. The accumulation of lipid-laden foam cells constitute the intermediate lesions or pathologic intimal thickening, which evolve through several stages of progression.
Arterial remodeling
Arterial remodeling involves a cascade of structural and morphological changes of a vessel wall in response to various stimuli including changes in blood flow and pressure, and acute injury; all three are common findings in atherosclerotic plaques. Two types of coronary arterial remodeling have been described: -Negative remodeling: defined as local shrinkage, negative remodeling is more often seen in patients with stable angina and is associated with smaller plaque areas. It might be seen in arterial wall healing after injuries such as balloon injury, that could be mainly related to vascular wall contracture and consequent luminal narrowing. The biological events involved in this wound healing involve complex series of interacting growth factors, integrins and proteases. -Positive or outward remodeling: defined by a compensatory increase in local vessel size in response to increasing plaque burden minimizing the degree of luminal stenosis. Positive remodeling characterizes unstable vulnerable plaques. There are studies demonstrating that plaque rupture occurs in insignificant, mildly occlusive plaques, this could be explained by positive remodeling: the increase in total arterial area that accompanies plaque accumulation. Large positive remodeled plaques while paradoxically protecting against luminal narrowing, are more susceptible to mechanical forces that lead to plaque rupture and an unstable clinical presentation. The pathogenesis of arterial remodeling is not fully understood and remains debated. Many hypotheses have been advanced. Arterial wall neovascularisation of atherosclerotic plaques seems to have a potential role in modulating lesion formation and structural changes of the arterial wall, by nourishing the growing plaque. Various angiogenic growth factors and receptors are implicated in coronary wall angiogenesis such as VEGF/VPF, estrogen, interleukin 8, bFGF, and aFGF; the role of TNF-and TGF-remains controversial. Angiotensine II via AT1 receptors is another trigger of plaque neovascularisation and remodeling. Activation of NADPH oxidase by various triggers such as Angiotensine II and mechanical stretch promotes ROS production and ROS-mediated pathways leading to vascular remodeling. In addition Low ESS leads to inflammation of the wall beneath the plaque and shift of the extracellular matrix balance toward degradation. Within such an environment the internal elastic lamina undergoes severe fragmentation, and the atherosclerotic process extends into the media degrading the collagen and elastin fibers, thereby promoting arterial expansion and outward remodeling. Human studies using intravascular ultrasound confirmed that outward or positive remodeling is more common at culprit lesion sites in patients with unstable angina, whereas inward or negative remodeling is more common in patients with stable angina.
Pathogenesis of positive arterial remodeling
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Plaque destabilisation
Typically a vulnerable plaque is described as having a thin fibrous cap and a rich superficial lipid core. Weakening of the fibrous cap is due mainly to accelerated degradation of collagen and other matrix components. Many factors contribute to plaque vulnerabilisation: 
Inflammation

Renin-angiotensin system
There is evidence of angiotensin converting enzyme (ACE), angiotensine II, and AT1 receptors within the plaque. An increased activity of ACE was found within culprits lesions in the setting of acute coronary syndromes, probably related to a local secretion. Angiotensine II increases the likelihood of plaque progression and rupture via AT1 receptors by regulating the gene expression of various bioactive substances mainly interleukine 6 (IL6), metalloproteinases, and other growth factors and cytokines. Angiotensine II also activates multiple intracellular signaling cascades (mitogen-activated protein kinase cascades, tyrosine kinases, and various transcription factors) in coronary endothelial and smooth muscle cells. In addition Angiotensine II enhances plaque neovascularisation. The spatial gradient of blood velocity from areas at the arterial wall toward areas at the center of the lumen (dv/dy, where dv is change in flow velocity and dy is change in radial distance from the wall). Physiologically, the shear rate decreases at the center of the lumen and gradually increases toward the wall. -Blood viscosity: A principal property of blood related to its internal friction that causes blood to resist flow. Hematocrit is the major determinant of blood viscosity. Although the entire vasculature is exposed to the atherogenic effects of the systemic risk factors such as hyperlipidemia, cigarette smoking, hypertension, diabetes mellitus, and genetic predisposition, atherosclerotic lesions form at specific regions of the arterial tree, such as in the vicinity of branch points, the outer wall of bifurcations, and the inner wall of curvatures, where disturbed flow occurs and ESS is low. Low ESS induces endothelial dysfunction by reducing the bioavailability of nitric oxid via a decrease in eNOS messenger ribonucleic acid and protein expression, thereby exposing the endothelium to the atherogenic effect of local and systemic risk factors. Nitric oxide is a key component of normal vascular tone, characterized by strong anti-inflammatory, antiapoptotic, anti-mitogenic, and anti-thrombotic properties. In addition, low ESS downregulates prostacyclin, another endothelial vasodilatory substance and upregulates endothelin-1, a potent vasoconstrictive and mitogenic molecule. Low ESS also promotes subendothelial deposition and accumulation of LDL-C by increasing mitotic and apoptotic activity of endothelial cells and inducing conformational changes of endothelial cells from fusiform to polygonal shape, widening thereby the junctions between endothelial cells. Gene expression as well as post-transcriptional activity of the major oxidative enzymes at endothelial cell membranes are enhanced by low ESS, leading to the production of reactive oxygen species within the intima. In addition gene expression of several adhesion molecules, chemoattractant chemokines and proinflammatory cytokines are upregulated by low ESS.
Mechanisms of low ESS mediated plaque weakening Endothelial dysfunction:
 Decreases eNOS  Downregulates Prostacycline synthesis  Upregulates Endotheline-1 synthesis Table 3 . This table summarizes the contribution of low ESS to plaque weakening.
LDL-C sub-intimal uptake and accumulation Promotes inflammation Promotes oxidative stress
Strenuous exercise
Strenuous exercise especially among those who exercise infrequently and have multiple cardiac risk factors, is associated with increased temporary risk of plaque rupture and myocardial infarction via increase wall stress due to rapid increase in heart rate and blood pressure, coronary vasospasm, increased flexing of epicardial coronary arteries, deepening of existing plaque fissures, and catecholamine induced platelet aggregation.
In vivo detection of vulnerable plaque with optical coherence tomography
Optical coherence tomography (OCT) is recently developed imaging modality, using infra red light and characterized by the higher existing resolution (axial resolution: 10-15μm) allowing a microscopical description of the atherosclerotic plaque in vivo within the coronary arteries. OCT is validated for the detection of vulnerable plaque wich is typically characterized by: -Thin fibrous cap < 65 μm -Rich lipid core: when lipid is present within two or more quadrants of the plaque. -Microchannels in case of plaque neovascularisation. Fig. 1 . Fibrous cap assessment with OCT: fibrous cap is a signal rich layer separating the lumen from the signal poor underlying lipid core. Fibrous cap is measured at its thinest segment. . Adventicial and subintimal increazed neovascularization characterizes unstable plaque and can be detected in vivo with OCT. Neovessels or microchannels are seen as nosignal tubulo-luminal structure without a connection to the vessel lumen and recognized on ≥ 3 consecutive cross sectional OCT images.
Plaque rupture
As previously explained the fibrous cap rupture results from an imbalance between synthesis and breakdown of extracellular matrix collagen and other matrix components leading to thinning of the cap, predisposing the cap to spontaneous rupture or rupture in response to a variety of triggers. Plaque rupture primarily occurs in yellowish plaques with an increased lipid core and thin fibrous cap. Rupture of the thin fibrous cap exposes blood flow to the lipid core. The lipid core is believed to be highly thrombogenic when exposed to circulating blood. The enhanced thrombogenicity of the lipid core has been attributed to the high levels of functionally active tissue factor most likely derived from the death of macrophages inside the plaque. In addition to tissue factor, oxidized lipids in the lipid core may also directly stimulate platelet aggregation. The thrombus is usually occlusive in STEMI and nonocclusive in NSTEMI. Episodes of plaque disruption and thrombosis may be subclinical and do not always result in acute coronary syndrome. Healing process may play an integral role in the progression of atherosclerosis, having the potential to cause sudden plaque growth.
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